Author:
Rubattu Speranza,Gallo Giovanna,Volpe Massimo
Abstract
The heart releases natriuretic peptides (NPs) which represent an important hormonal axis with cardiorenal protective effects. In view of their properties, NPs have pathophysiologic, diagnostic and prognostic implications in several cardiovascular diseases (CVDs). Severe pulmonary inflammation, as induced by the SARS-COV2, may increase pulmonary pressure with potential influence on NPs release, whereby normal cardiovascular integrity becomes impaired. Moreover, pre-existing CVDs are strong negative prognostic factors since they exacerbate the effects of the viral infection and lead to worse outcomes. In this context, it may be expected that NPs exert a key protective role toward the virus infection whereas an impairment of NPs release contributes to the virus deleterious effects. In this review article we explore the potential involvement of NPs in the COVID-19 disease. To this aim, we will first focus on the interactions between NPs and the Ang II/ATIR arm of the renin-angiotensin-aldosterone system (RAAS) as well as with the protective ACE2/Ang (1-7) arm of the RAAS. Subsequently, we will review evidence that strongly supports the role of increased NT-proBNP level as a marker of cardiac damage and of worse prognosis in the COVID-19 affected patients. Finally, we will discuss the potential therapeutic benefits of these protective hormones toward the viral infection through their endothelial protective function, anti-inflammatory and anti-thrombotic effects. In conclusion, the potential implications of NPs in the SARS-CoV-2 infection, as discussed in our article, represent an important issue that deserves to be fully investigated.
Subject
Physiology (medical),Physiology
Reference46 articles.
1. Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients.;Acanfora;Eur. Heart J. Cardiovasc. Pharmacother.,2020
2. Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients.;Arcari;Intern. Emerg. Med.,2020
3. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.;Atlas;Fed. Proc.,1986
4. Aminoterminal natriuretic peptide as a determinant of PAI-1 levels in a sample of the adult male Italian population.;Barbato;J. Thromb. Haemost.,2011
5. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers.;Baron;Proc. Natl. Acad. Sci. U.S.A.,1989
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献